Edges in Network
| Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | SMAD2 |
| Upstream (Parents) |
|---|
| (<<) ATF2 → SMAD2 |
| (<<) DYRK1A → SMAD2 |
| (<<) EPHA1 → SMAD2 |
| (<<) GNG10 → SMAD2 |
| (<<) MAPK9 → SMAD2 |
| (<<) RNF138 → SMAD2 |
| (<<) ROCK2 → SMAD2 |
| (<<) STAM2 → SMAD2 |
| (<<) UBQLN2 → SMAD2 |
| Downstream (Children) |
|---|
| SMAD2 → ATP2C1 (>>) |
| SMAD2 → CDK8 (>>) |
| SMAD2 → CRLF3 (>>) |
| SMAD2 → E2F6 (>>) |
| SMAD2 → EZR (>>) |
| SMAD2 → F2RL1 (>>) |
| SMAD2 → FZD5 (>>) |
| SMAD2 → HCN2 (>>) |
| SMAD2 → PLA2G12A (>>) |
| SMAD2 → RAB15 (>>) |
| SMAD2 → RHOT1 (>>) |
| SMAD2 → RRP15 (>>) |
| SMAD2 → SEH1L (>>) |
| SMAD2 → SMO (>>) |
| SMAD2 → STAT5B (>>) |
| SMAD2 → TUBA1A (>>) |
| SMAD2 → WNT5A (>>) |
| SMAD2 → WNT6 (>>) |
